|
|
|
|
|
|
|
|
RECOMMENDATION: Healthcare professionals should screen patients prior to administration of a GBCA to identify those with acute kidney injury or chronic, severe, kidney disease. See the Drug Safety Communication for the complete list of recommendations to healthcare professionals and patients.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.